An AI-driven model using 30 years of EHR data enhances screening for primary aldosteronism, a frequently underdiagnosed hypertension cause.
Key Details
- 1Study presented at ENDO 2026 by Mayo Clinic researchers, using Mayo Clinic Platform data from 1986–2025.
- 2AI model analyzed clinical variables: age, gender, ICD codes for hypertension/hypokalemia, blood pressure, potassium levels, and prescriptions.
- 3Model was developed with over 22,000 patients, tested on 225,887 hypertensive adults.
- 4XGBoost architecture predicted primary aldosteronism risk 12 months before diagnosis.
- 5At low-risk threshold, the model flagged >90% of cases while missing <10%, identifying about two-thirds for further screening.
Why It Matters
This AI tool addresses a major gap in early detection of a serious but often-missed hypertension cause, enabling targeted intervention that can lower cardiovascular morbidity and healthcare costs. The study demonstrates powerful potential for machine-learning models in analyzing routine clinical data to guide large-scale, cost-effective diagnosis in at-risk populations.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.